Your browser is no longer supported. Please, upgrade your browser.
Settings
AMRX Amneal Pharmaceuticals, Inc. daily Stock Chart
AMRX [NYSE]
Amneal Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.61 Insider Own0.20% Shs Outstand316.70M Perf Week29.35%
Market Cap1.51B Forward P/E9.92 EPS next Y0.48 Insider Trans0.00% Shs Float100.39M Perf Month73.09%
Income-338.80M PEG- EPS next Q0.04 Inst Own81.50% Short Float5.25% Perf Quarter42.51%
Sales1.73B P/S0.87 EPS this Y97.50% Inst Trans1.09% Short Ratio2.15 Perf Half Y-31.01%
Book/sh1.67 P/B2.85 EPS next Y54.34% ROA-8.10% Target Price4.36 Perf Year-70.85%
Cash/sh0.67 P/C7.09 EPS next 5Y5.93% ROE-81.80% 52W Range2.27 - 16.85 Perf YTD-64.82%
Dividend- P/FCF6.04 EPS past 5Y-16.10% ROI-1.30% 52W High-71.75% Beta1.54
Dividend %- Quick Ratio1.50 Sales past 5Y26.60% Gross Margin31.80% 52W Low109.69% ATR0.41
Employees6000 Current Ratio2.30 Sales Q/Q-20.60% Oper. Margin-0.20% RSI (14)69.14 Volatility10.55% 8.85%
OptionableYes Debt/Eq12.44 EPS Q/Q- Profit Margin-19.60% Rel Volume3.64 Prev Close5.04
ShortableYes LT Debt/Eq12.34 EarningsNov 06 BMO Payout- Avg Volume2.45M Price4.76
Recom2.80 SMA2038.07% SMA5049.52% SMA200-27.66% Volume8,901,000 Change-5.56%
Dec-12-19Downgrade Raymond James Outperform → Mkt Perform
Nov-12-19Downgrade JP Morgan Neutral → Underweight
Nov-07-19Downgrade SVB Leerink Outperform → Mkt Perform
Jul-22-19Upgrade SVB Leerink Mkt Perform → Outperform $11 → $5
Jul-11-19Downgrade RBC Capital Mkts Outperform → Sector Perform $11 → $6
Jul-08-19Upgrade Piper Jaffray Neutral → Overweight
Jun-11-19Initiated Barclays Equal Weight $9
May-21-19Upgrade Raymond James Mkt Perform → Strong Buy $13
Mar-20-19Initiated SunTrust Buy $16
Mar-08-19Downgrade SVB Leerink Outperform → Mkt Perform $16 → $12
Dec-14-18Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-16-18Downgrade SunTrust Buy → Hold
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Jul-23-18Initiated Morgan Stanley Overweight $22
Jun-22-18Initiated B. Riley FBR, Inc. Buy $26
Dec-13-19 09:23AM  Company News for Dec 13, 2019 Zacks -5.56%
08:54AM  Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals (AMRX) Stock? Zacks
Dec-12-19 12:08PM  Amneal Pharmaceuticals (AMRX): A Battered Stock on the Rise TipRanks +44.83%
12:01PM  Heres Why Amneal Pharmaceuticals (AMRX) Stock Skyrocketed 50% Today SmarterAnalyst
09:05AM  Amneal stock jumps on launch of first generic NuvaRing MarketWatch
06:59AM  Amneal Receives Abbreviated New Drug Application Approval for EluRyng, the First Generic NuvaRing® Business Wire
Dec-10-19 06:59AM  Amneal to Acquire Majority Interest in AvKARE, Enhancing Access to Growing Federal Healthcare Market Business Wire
Dec-03-19 08:00AM  Amneal Announces the Approval and Launch of Generic Carafate® Business Wire +5.21%
07:59AM  The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial Benzinga
Dec-02-19 04:05PM  Amneal Announces the Approval and Launch of Generic Revatio® for Oral Suspension and Generic Amicar® Tablets Business Wire
Nov-27-19 12:36PM  Possible criminal probe undermines recovery in opioid stocks since global legal settlement announced MarketWatch +7.89%
07:34AM  Fed Reportedly Opens Criminal Investigation on Opioid Makers Zacks
06:14AM  Pharma Companies Shares Tank As Feds Investigate Opioid Crisis Benzinga
Nov-26-19 01:21PM  Shares of opioid makers and distributors drop on criminal probe MarketWatch -10.06%
08:05AM  Amneal Pharmaceuticals to Present at the Piper Jaffray 31st Annual Healthcare Conference TEST Business Wire Releases
08:05AM  Amneal Pharmaceuticals to Present at the Piper Jaffray 31st Annual Healthcare Conference Business Wire
Nov-19-19 04:54PM  Teva, Bausch Could Be Next to File for Bankruptcy GuruFocus.com +7.42%
Nov-12-19 10:47AM  Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other Benzinga
09:30AM  Teva Pharmaceuticals Prospects Are Improving, Analyst Says. Hes Downbeat on a Rival. Barrons.com
Nov-07-19 02:30PM  7 Stocks the Vanguard Health Care Fund Keeps Buying GuruFocus.com
Nov-06-19 09:45AM  Amneal Pharmaceuticals (AMRX) Lags Q3 Earnings and Revenue Estimates Zacks -19.77%
06:32AM  Amneal Reports Third Quarter 2019 Financial Results Business Wire
06:30AM  Amneal Enters into a Licensing Agreement with Kashiv BioSciences, LLC to Develop and Commercialize K127 for the Treatment of Myasthenia Gravis Business Wire
Oct-30-19 10:34AM  Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline Zacks -6.45%
Oct-21-19 10:01AM  Is Amneal Pharmaceuticals, Inc. (AMRX) Going To Burn These Hedge Funds ? Insider Monkey
Oct-11-19 01:50PM  Some Amneal Pharmaceuticals (NYSE:AMRX) Shareholders Have Taken A Painful 85% Share Price Drop Simply Wall St. -5.88%
Oct-10-19 09:25AM  Amneal Announces Launch of Generic Invega® Business Wire
Oct-09-19 08:30AM  Amneal to Report Third Quarter 2019 Results on November 6, 2019 Business Wire -6.60%
Aug-22-19 12:16PM  Amneal Pharmaceuticals, Inc. (AMRX) Q2 2019 Earnings  Call Transcript Motley Fool
Aug-09-19 04:09PM  Largest Insider Trades of the Week GuruFocus.com
Aug-08-19 11:13AM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amneal Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Aug-05-19 12:15PM  Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Lag Estimates Zacks -7.08%
06:01AM  Amneal Reports Second Quarter 2019 Financial Results Business Wire
06:00AM  Amneal Pharmaceuticals Co-Founders Chirag Patel and Chintu Patel Return as Co-Chief Executive Officers Business Wire
Aug-01-19 10:33AM  Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-26-19 05:25PM  Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group PR Newswire
09:30AM  ASRT or AMRX: Which Is the Better Value Stock Right Now? Zacks
Jul-24-19 04:42PM  AMRX INVESTIGATION ALERT: Bernstein Liebhard LLP Announces Investigation of Amneal Pharmaceuticals Inc. AMRX GlobeNewswire
Jul-23-19 11:43AM  ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amneal Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire +6.69%
Jul-22-19 04:09PM  These Pharmas Could Be On The Hook For Billions In The Opioid Epidemic Investor's Business Daily
07:00AM  Amneal Announces Launch of Generic Lyrica® Business Wire
Jul-18-19 03:57PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amneal Pharmaceuticals, Inc. - AMRX GlobeNewswire
Jul-16-19 11:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amneal Pharmaceuticals, Inc. - AMRX CNW Group -6.84%
Jul-15-19 12:02PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amneal Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire -5.14%
10:35AM  Morgan Stanley Downgrades Teva, Endo On Drug Pricing And Litigation Concerns Benzinga
Jul-14-19 09:22AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amneal Pharmaceuticals, Inc. - AMRX ACCESSWIRE
Jul-12-19 10:50PM  AMNEAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amneal Pharmaceuticals, Inc. - AMRX Business Wire -8.64%
Jul-11-19 04:21PM  Amneal (AMRX) Down on Guidance Update & Restructuring Plan Zacks -7.11%
12:17PM  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amneal Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:54AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) ACCESSWIRE
10:10AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Amneal Pharmaceuticals, Inc. AMRX Business Wire
06:17AM  The Daily Biotech Pulse: Neurocrine's Parkinson's Drug Accepted For Review, Sunesis Offering, No Headaches For Biohaven's Migraine Drug Benzinga
Jul-10-19 11:17PM  INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amneal Pharmaceuticals, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm Business Wire -35.98%
04:48PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amneal Pharmaceuticals, Inc. - AMRX GlobeNewswire
04:33PM  Why Micro Focus International, MSC Industrial Direct, and Amneal Pharmaceuticals Slumped Today Motley Fool
11:34AM  Here's Why Amneal Pharmaceuticals Fell as Much as 36.6% Today Motley Fool
07:39AM  Amneal Announces Restructuring Plan, Cuts Guidance Benzinga
07:35AM  UPDATE 1-Amneal Pharma cuts core profit forecast on allergy shot supply issues Reuters
07:04AM  Amneal Pharma slashes core earnings forecast on allergy shot supply issues Reuters
06:45AM  Amneal Pharmaceuticals Announces Restructuring and Costs Savings Plan to Improve Operations and Position the Company for Future Growth Business Wire
Jul-09-19 08:45AM  Amneal to Report Second Quarter 2019 Results on August 8, 2019 Business Wire
Jul-02-19 12:03PM  Drugmakers raised prices of over 40 prescription drugs Yahoo Finance Video
Jun-26-19 09:30PM  Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Rockwell Medical, Amneal Pharmaceuticals and Intuit and Encourages Investors to Contact the Firm GlobeNewswire
Jun-18-19 11:09AM  Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Rockwell Medical, Amneal Pharmaceuticals, Kraft Heinz, and Intuit and Encourages Investors to Contact the Firm GlobeNewswire
Jun-14-19 10:50PM  AMNEAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amneal Pharmaceuticals, Inc. - AMRX PR Newswire -6.40%
Jun-12-19 06:29AM  Barclays Has New Plays for Healthcare Fans SmarterAnalyst
Jun-06-19 08:35AM  Amneal Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
May-24-19 05:02PM  An Antitrust Lawsuit Could Cost Generic Pharmas Billions Of Dollars Investor's Business Daily
03:14PM  Need To Know: Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Insiders Have Been Selling Shares Simply Wall St.
May-17-19 10:50PM  AMNEAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amneal Pharmaceuticals, Inc. - AMRX Business Wire
May-15-19 09:25AM  Amneal Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference Business Wire
May-13-19 05:49PM  AMNEAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Amneal Pharmaceuticals, Inc. To Contact The Firm PR Newswire -14.49%
May-09-19 04:54PM  Amneal Pharmaceuticals, Inc. (AMRX) Q1 2019 Earnings Call Transcript Motley Fool -15.98%
12:52PM  Why Amneal Pharmaceuticals Stock Is Cratering Today Motley Fool
07:55AM  Amneal Pharmaceuticals (AMRX) Misses Q1 Earnings Estimates Zacks
06:49AM  Amneal: 1Q Earnings Snapshot Associated Press
06:30AM  Amneal Reports First Quarter 2019 Financial Results Business Wire
Apr-25-19 11:50AM  Heres What Hedge Funds Think About Amneal Pharmaceuticals, Inc. (AMRX) Insider Monkey
Apr-08-19 08:05AM  Amneal to Report First Quarter 2019 Results on May 9, 2019 Business Wire
Apr-02-19 07:00AM  Amneal Names Pradeep Bhadauria as Chief Scientific Officer Business Wire
Apr-01-19 08:31AM  Amneal Announces Agreement with Zentiva to Divest Creo Pharma PR Newswire
Mar-13-19 08:15PM  Amneal Pharmaceuticals Inc (AMRX) President and CEO Robert A Stewart Bought $202,640 of Shares GuruFocus.com +12.79%
Mar-12-19 07:15PM  Amneal Pharmaceuticals Inc (AMRX) President and CEO Robert A Stewart Bought $202,640 of Shares GuruFocus.com
08:30AM  Amneal Announces Launch of Rivastigmine Transdermal System PR Newswire
Mar-06-19 08:35AM  Amneal Pharmaceuticals to Present at the Barclays Global Healthcare Conference PR Newswire
Mar-05-19 08:29AM  New Strong Sell Stocks for March 5th Zacks
Mar-01-19 09:48PM  Amneal Pharmaceuticals Inc (AMRX) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
09:59AM  Amneal Pharmaceuticals (AMRX) Surges: Stock Moves 8.6% Higher Zacks
Feb-28-19 11:38AM  Amneal Pharmaceuticals, Inc. (AMRX) Q4 2018 Earnings Conference Call Transcript Motley Fool +8.67%
07:30AM  Amneal Reports Fourth Quarter And Full Year 2018 Financial Results PR Newswire
Feb-04-19 05:39PM  Genentech files flurry of lawsuits to protect $100,000-a-year drug American City Business Journals
Jan-24-19 07:30AM  Amneal to Report Fourth Quarter and Full Year 2018 Results on February 28, 2019 PR Newswire
Jan-22-19 09:26AM  Does Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Have A Place In Your Portfolio? Simply Wall St.
06:55AM  Amneal Names Accomplished Finance Executive Todd P. Branning As Chief Financial Officer PR Newswire
Jan-14-19 07:30AM  Amneal Announces Approval of Rivastigmine Transdermal System PR Newswire
Jan-04-19 07:30AM  Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary PR Newswire +9.28%
Dec-19-18 08:35AM  Amneal Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire -5.78%
Dec-15-18 02:01AM  Hedge Funds Arent Crazy About Alta Mesa Resources, Inc. (AMR) Anymore Insider Monkey
Nov-22-18 08:31AM  J&J Loses Appeal to Halt Generic Zytiga Launch, Stock Down Zacks
Nov-21-18 08:35AM  Amneal to Present at the 30th Annual Piper Jaffray Healthcare Conference PR Newswire
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. It operates through two segments, Generics and Specialty. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders and parasitic infections. It also offers licensed and owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinsons Disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The company has operations in the United States, Switzerland, India, Ireland, the United Kingdom and internationally. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.